Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thrombosis and thrombolysis 1999-06, Vol.7 (3), p.233
Hauptverfasser:	McCullough, P A, Marks, K R
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia, Aplastic - chemically induced Angioplasty, Balloon, Coronary Aspirin - administration & dosage Aspirin - adverse effects Aspirin - therapeutic use Clinical Trials as Topic Coronary Disease - therapy Coronary Thrombosis - prevention & control Drug Therapy, Combination Health Policy Hematologic Diseases - chemically induced Hematologic Diseases - mortality Hemorrhage - chemically induced Humans Multivariate Analysis Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Practice Guidelines as Topic Premedication Purpura, Thrombotic Thrombocytopenic - chemically induced Randomized Controlled Trials as Topic Retrospective Studies Risk Stents Ticlopidine - administration & dosage Ticlopidine - adverse effects Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!